MORGAN STANLEY PLC/CALL/PFIZER INC/40/0.1/20.12.24 Stock

Warrant

DE000MB333C5

Delayed Börse Stuttgart 03:20:59 2024-06-27 EDT
0.015 EUR -6.25% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/40/0.1/20.12.24
1 month-20.00%
3 months-70.37%
Date Price Change
24-06-27 0.015 -6.25%
24-06-26 0.016 +14.29%
24-06-25 0.014 -6.67%
24-06-24 0.015 0.00%
24-06-21 0.015 -6.25%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 03:20 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB333C
ISINDE000MB333C5
Date issued 2023-02-01
Strike 40 $
Maturity 2024-12-20 (177 Days)
Parity 10 : 1
Emission price 0.95
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.81
Lowest since issue 0.013
Delta0.09x
Omega 8.830
Premium46.95x
Gearing93.23x
Moneyness 0.6855
Difference Strike 12.58 $
Difference Strike %+31.45%
Spread 0.025
Spread %62.50%
Theoretical value 0.0275
Implied Volatility 38.36 %
Total Loss Probability 94.15 %
Intrinsic value 0.000000
Present value 0.0275
Break even 40.29 €
Theta-0x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.42 USD
Average target price
31.92 USD
Spread / Average Target
+16.39%
Consensus